Next Article in Journal
Augmenting Vaccine Efficacy against Delta Variant with ‘Mycobacterium-w’-Mediated Modulation of NK-ADCC and TLR-MYD88 Pathways
Next Article in Special Issue
Children’s SARS-CoV-2 Infection and Their Vaccination
Previous Article in Journal
Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial
Previous Article in Special Issue
Anti-SARS-CoV-2 IgM Secondary Response Was Suppressed by Preexisting Immunity in Vaccinees: A Prospective, Longitudinal Cohort Study over 456 Days
 
 
Article

Article Versions Notes

Vaccines 2023, 11(2), 327; https://doi.org/10.3390/vaccines11020327
Action Date Notes Link
article xml file uploaded 1 February 2023 07:01 CET Original file -
article xml uploaded. 1 February 2023 07:01 CET Update https://www.mdpi.com/2076-393X/11/2/327/xml
article pdf uploaded. 1 February 2023 07:01 CET Version of Record https://www.mdpi.com/2076-393X/11/2/327/pdf
article html file updated 1 February 2023 07:02 CET Original file -
article html file updated 1 March 2023 12:00 CET Update https://www.mdpi.com/2076-393X/11/2/327/html
Back to TopTop